1-9 of 9
warfarin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction

Clinical Trials & Observations
Claudia Hanni, Elizabeth Petrovitch, Mona Ali, Whitney Gibson, Christopher Giuliano, Jenna Holzhausen, Charles Makowski, Amy Pallisco, Nisha Patel, Denise Sutter, Long To, Raymond Yost
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2366–2371.
https://doi.org/10.1182/bloodadvances.2019000972
Published: 2020
Journal Articles

Competitive tight-binding inhibition of VKORC1 underlies warfarin dosage variation and antidotal efficacy

Shuang Li, Shixuan Liu, Xiaoran Roger Liu, Mengru Mira Zhang, Weikai Li
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2202–2212.
https://doi.org/10.1182/bloodadvances.2020001750
Published: 2020
Includes: Supplemental data
Journal Articles

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis

Clinical Trials & Observations
Leonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Kevin Troy, Thomas Schiano, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (4): 655–666.
https://doi.org/10.1182/bloodadvances.2019001310
Published: 2020
Journal Articles

Bleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses

Derek Weycker, Gail DeVecchis Wygant, Jennifer D. Guo, Theodore Lee, Xuemei Luo, Lisa Rosenblatt, Jack Mardekian, Mark Atwood, Ahuva Hanau, Alexander T. Cohen
Journal: Blood Advances
Blood Adv (2020) 4 (2): 432–439.
https://doi.org/10.1182/bloodadvances.2019001081
Published: 2020
Includes: Supplemental data
Journal Articles

Managing patients who are receiving warfarin or a direct oral anticoagulant and need an elective surgery or procedure

James Douketis, Andrea Cervi
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1925.
https://doi.org/10.1182/bloodadvances.2019000171
Published: 2019
Includes: Supplemental data
Journal Articles

Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients

Clinical Trials & Observations
Hideki Yoshioka, Hiromi Sato, Hiroto Hatakeyama, Akihiro Hisaka
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1066–1075.
https://doi.org/10.1182/bloodadvances.2017013805
Published: 2018
Includes: Supplemental data
Journal Articles

VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites

Katrin J. Czogalla, Kerstin Liphardt, Klara Höning, Veit Hornung, Arijit Biswas, Matthias Watzka, Johannes Oldenburg
Journal: Blood Advances
Blood Adv (2018) 2 (6): 691–702.
https://doi.org/10.1182/bloodadvances.2017006775
Published: 2018
Includes: Supplemental data
Journal Articles

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Clinical Trials & Observations
Surbhi Shah, Faye L. Norby, Yvonne H. Datta, Pamela L. Lutsey, Richard F. MacLehose, Lin Y. Chen, Alvaro Alonso
Journal: Blood Advances
Blood Adv (2018) 2 (3): 200–209.
https://doi.org/10.1182/bloodadvances.2017010694
Published: 2018
Includes: Supplemental data
Journal Articles

Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants

Clinical Trials & Observations
Jordan K. Schaefer, Suman L. Sood, Brian Haymart, Xiaokui Gu, Xiaowen Kong, Eva Kline-Rogers, Steven Almany, Jay Kozlowski, Gregory D. Krol, Scott Kaatz, James B. Froehlich, Geoffrey D. Barnes
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2536–2540.
https://doi.org/10.1182/bloodadvances.2017012377
Published: 2017